About Chugai
Chugai’s mission is
to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- May 08, 2024 Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure - Improving access to the clinical trial for patients far from the institution -
- Apr 30, 2024 CHMP Recommends EU Approval of Alecensa as an Adjuvant Treatment for Resected ALK-Positive Early-Stage Lung Cancer
- Apr 26, 2024 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
- Apr 24, 2024 Chugai Announces 2024 1st Quarter Results
- Apr 24, 2024 F. Hoffmann-La Roche Announces First Quarter Sales 2024